Cited by 142Gastrointestinal motility and disordersGastrointestinal Bleeding Diagnosis and TreatmentGastroesophageal reflux and treatments

Epidemiology, Etiology, and Treatment of Gastroparesis: Real-World Evidence From a Large US National Claims Database

Open access
Ye, Yizhou, Yin, Yu, Huh, Susanna Y., Almansa, Cristina, Bennett, Dimitri, Camilleri, Michael·2022·Gastroenterology

Abstract

Background & aims Although gastroparesis carries a considerable health care and patient burden, associated epidemiological data are limited. To provide new real-world evidence for gastroparesis, we estimated disease prevalence, and investigated patient demographics and disease etiology in a large US claims database. Methods This retrospective, cross-sectional analysis used de-identified, longitudinal patient-level enrollment and billing data for adults from the Optum Clinformatics Data Mart database, a large US national administrative health insurance claims database. Prevalence was age-, sex-, and geographical region-standardized using the 2018 US census. Descriptive analyses of demographic and clinical variables and underlying disease etiologies were performed. Results The overall standardized prevalence of gastroparesis was 267.7 (95% confidence interval [CI] 264.8-270.7) per 100,000 US adults, whereas prevalence of "definite" gastroparesis (individuals diagnosed within 3 months of gastric emptying scintigraphy testing with persistent symptoms for more than 3 months) was 21.5 (95% CI 20.6-22.4) per 100,000 persons. Patients with gastroparesis had an overall Charlson Comorbidity Index score of 4.2, indicating substantial comorbidity burden. The most frequently documented comorbidities were chronic pulmonary disease (46.4%), diabetes with chronic complication (37.3%), and peripheral vascular disease (30.4%). Patients most commonly had a diabetic etiology (57.4%; type 1, 5.7%…

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2021.09.064

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies applying stricter criteria for "definite gastroparesis" show that diabetic etiology represents the leading cause of gastroparesis among identified etiologies, accounting for approximately 57.4% of all reported cases in large national claims databases.

    “In contrast, studies applying stricter criteria for “definite gastroparesis”, show that diabetic etiology represents the leading cause of gastroparesis among identified etiologies, accounting for approximately 57.4% of all reported cases in large national claims databases [10].”
  • A large study conducted in 2020 on more than 43 million medical records in the United States reported that only 0.16% of patients had a documented diagnosis of gastroparesis.

    “For example, a large study conducted in 2020 on more than 43 million medical records in the United States reported that only 0.16% of patients had a documented diagnosis of gastroparesis [9, 10].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ye, Y., Yin, Y., Huh, S. Y., Almansa, C., Bennett, D., & Camilleri, M.
Affiliations
  • Takeda (United States) (US)
  • Mayo Clinic (US)
Corresponding author
Bennett, Dimitri
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2022-01
Volume
162
Issue
1
Pages
109-121.e5
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3204205013
Cited by
142
References
0
Citations by year
2026: 31 · 2025: 35 · 2024: 35 · 2023: 24 · 2022: 16 · 2021: 1
FWCI
17.36
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Takeda Pharmaceutical Co Ltd
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
gastroparesis, prevalence, etiology, diabetic gastroparesis, type 2 diabetes, type 1 diabetes, postoperative gastroparesis, idiopathic gastroparesis, comorbidities, Charlson Comorbidity Index, gastric emptying scintigraphy, healthcare burden, patient demographics
MeSH terms
Administrative Claims, Healthcare, Adolescent, Adult, Age Factors, Aged, Cross-Sectional Studies, Female, Gastric Emptying, Humans, Male, Middle Aged, Predictive Value of Tests, Retrospective Studies, Risk Factors, Sex Factors, Time Factors, United States, Comorbidity, Prevalence, Databases, Factual, Treatment Outcome, Risk Assessment, Gastroparesis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review